Sign in
4

Changes in Ownership

Oncotelic Therapeutics, Inc. Filed Acc 0001181431-07-008787

Options or other derivatives

  • Chief Scientific Officer acquired 25,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

CHAPLIN DAVID · Chief Scientific Officer

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2007-01-25 Grant or award : show line 1 in the form Option to Purchase Common Stock +25,000 25,000 D
Loading xslF345X02/rrd145069.xml…